SPL - Starwin Products Limited
Starwin Products Limited is a pharmaceutical manufacturer based in Ghana. It traces its history to 1960 when Sterling Products International, an American pharmaceutical company, incorporated a subsidiary in Ghana. In 1976, the company sold 50% of its stock to a group of Ghanaian investors. The group eventually bought the remaining shares of the company in 1987 and subsequently changed the name to Starwin Products Limited. The company's product line includes Rapinol, Asmadrin, Painoff, Paraking, milk of magnesia and liver salts.
|Last Trading Results||Growth & Valuation|
|Opening Price:||--||Earnings Per Share:||0.0032|
|Day's Low Price:||--||Price/Earning Ratio:||9.30|
|Day's High Price:||--||Dividend Per Share:||0.00|
|Traded Volume:||0||Dividend Yield:||0%|
|Number of Deals:||0||Shares Outstanding:||259.81m|
SPL Stock Market Performance
The stock of Starwin Products Limited (SPL) is currently trading at 0.03 GHS per share on the Ghana Stock Exchange. SPL began the year with a share price of 0.02 GHS and has since gained 50% on that price valuation, ranking it 2nd on the GSE in terms of year-to-date performance. The table below details the last 10 trading days of activity of Starwin Products Limited on the Ghana Stock Exchange.
Profile of Starwin Products Limited
Starwin Products Limited operates in the Health Care sector. Unfortunately, we do not have information on the company's board of directors and/or key executives at this time.
|Factsheet of Starwin Products Limited|
P. O. Box 5760, Accra-North
SPL Industrial Market Competitors
Starwin Products Limited, issuers of the SPL stock on the Ghana Stock Exchange, have two market competitors who are also engaged in the Health Care sector. The table below gives you an overview of their market standing.
|Code||Name||Mkt. Cap.||L. Price||YearTD|
|AYRTN||Ayrton Drugs Manufacturing Co.||17.20m||0.08||+14.3%|
|IIL||Intravenous Infusions Limited||12.94m||0.05||-37.5%|